Epic Sciences, Inc.

Liquid biopsy could transform cancer care, but costs continue to be a major obstacle to liquid biopsy adoption and use, particularly in developing geographies. From discovery to treatment and to recur

Liquid biopsy could transform cancer care, but costs continue to be a major obstacle to liquid biopsy adoption and use, particularly in developing geographies. From discovery to treatment and to recur

Epic Sciences ’s DefineMBC laboratory developed liquid biopsy test has been designed to aid clinicians in the identification and classification of metastatic breast cancer. In May, Epic Sciences rele

[ Editor's note: This is the second of a two-part series on the liquid biopsy market. Check out the first article, providing a market overview a look at some of the larger players, here . ] Dozens o